MENOMUNE-A/C/Y/W-135
MENOMUNE-A/C/Y/W-135
Discontinued
DIN Number
02161184
Drug Class
Human
Market Date
Aug 13, 1998
Company
HC
aventis pasteur limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02161184
AIG Number0440084003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AH04 MENINGOCOCCUS, A, C, Y, W-135, TETRAVAL. PURIFIED POLYSACC. ANTIGEN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP AActive
Strength: 2.5 MG / KIT
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP CActive
Strength: 2.5 MG / KIT
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135Active
Strength: 2.5 MG / KIT
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP YActive
Strength: 2.5 MG / KIT
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y